The DOI matches its Crossref record; 29 of the 29 references it cites were found in a registry or an index.
Safety and Efficacy of a Totally Subcutaneous Implantable-Cardioverter Defibrillator
Abstract
Background—: The most frequent complications associated with implantable cardioverter-defibrillators (ICDs) involve the transvenous leads. A subcutaneous implantable cardioverter-defibrillator (S-ICD) has been developed as an alternative system. This study evaluated the safety and effectiveness of the S-ICD System (Cameron Health/Boston Scientific) for the treatment of life-threatening ventricular arrhythmias (ventricular tachycardia/ventricular fibrillation). Methods and Results—: This prospective, nonrandomized, multicenter trial included adult patients with a standard indication for an ICD, who neither required pacing nor had documented pace-terminable ventricular tachycardia. The primary safety end point was the 180-day S-ICD System complication-free rate compared with a prespecified performance goal of 79%. The primary effectiveness end point was the induced ventricular fibrillation conversion rate compared with a prespecified performance goal of 88%, with success defined as 2 consecutive ventricular fibrillation conversions of 4 attempts. Detection and conversion of spontaneous episodes were also evaluated. Device implantation was attempted in 321 of 330 enrolled patients, and 314 patients underwent successful implantation. The cohort was followed for a mean duration of 11 months. The study population was 74% male with a mean age of 52±16 years and mean left ventricular ejection fraction of 36±16%. A previous transvenous ICD had been implanted in 13%. Both primary end points were met: The 180-day system complication-free rate was 99%, and sensitivity analysis of the acute ventricular fibrillation conversion rate was >90% in the entire cohort. There were 38 discrete spontaneous episodes of ventricular tachycardia/ventricular fibrillation recorded in 21 patients (6.7%), all of which successfully converted. Forty-one patients (13.1%) received an inappropriate shock. Conclusions—: The findings support the efficacy and safety of the S-ICD System for the treatment of life-threatening ventricular arrhythmias. Clinical Trial Registration—: URL: http://www.clinicaltrials.gov . Unique identifier: NCT01064076.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Moss, A. J., Zareba, W., Hall, W. J., Klein, H., Wilber, D. J., Cannom, D. S., Daubert, J. P., Higgins, S. L., Brown, M. W., & Andrews, M. L. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa013474 · Cited by 6,902
Amiodarone or an Implantable Cardioverter–Defibrillator for Congestive Heart Failure
Bardy, G. H., Lee, K. L., Mark, D. B., Poole, J. E., Packer, D. L., Boineau, R., Domanski, M., Troutman, C., Anderson, J., Johnson, G., et al. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa043399 · Cited by 6,552
Self-citationMoss, A. J., Hall, W. J., Cannom, D. S., Daubert, J. P., Higgins, S. L., Klein, H., Levine, J. H., Saksena, S., Waldo, A. L., Wilber, D., et al. (1996) · New England Journal of Medicine · doi:10.1056/nejm199612263352601 · Cited by 4,165
(1997) · New England Journal of Medicine · doi:10.1056/nejm199711273372202 · Cited by 3,232
Writing Committee Members, Epstein, A. E., DiMarco, J. P., Ellenbogen, K. A., Estes, N. A. M., Freedman, R. A., Gettes, L. S., Gillinov, A. M., Gregoratos, G., Hammill, S. C., et al. (2008) · Circulation · doi:10.1161/circualtionaha.108.189742 · Cited by 1,774
Prognostic Importance of Defibrillator Shocks in Patients with Heart Failure
Poole, J. E., Johnson, G. W., Hellkamp, A. S., Anderson, J., Callans, D. J., Raitt, M. H., Reddy, R. K., Marchlinski, F. E., Yee, R., Guarnieri, T., et al. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa071098 · Cited by 1,462
Self-citationReduction in Inappropriate Therapy and Mortality through ICD Programming
Moss, A. J., Schuger, C., Beck, C. A., Brown, M. W., Cannom, D. S., Daubert, J. P., Estes, N. A. M., Greenberg, H., Hall, W. J., Huang, D. T., et al. (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1211107 · Cited by 1,378
Mirowski, M., Reid, P. R., Mower, M. M., Watkins, L., Gott, V. L., Schauble, J. F., Langer, A., Heilman, M. S., Kolenik, S. A., Fischell, R. E., et al. (1980) · New England Journal of Medicine · doi:10.1056/nejm198008073030607 · Cited by 1,361
WILKOFF, B. L., HESS, M., YOUNG, J., & ABRAHAM, W. T. (2004) · Journal of Cardiovascular Electrophysiology · doi:10.1046/j.1540-8167.2004.03625.x · Cited by 835
An Entirely Subcutaneous Implantable Cardioverter–Defibrillator
Bardy, G. H., Smith, W. M., Hood, M. A., Crozier, I. G., Melton, I. C., Jordaens, L., Theuns, D., Park, R. E., Wright, D. J., Connelly, D. T., et al. (2010) · New England Journal of Medicine · doi:10.1056/nejmoa0909545 · Cited by 780
Self-citation
Cited by
Priori, S. G., Blomström-Lundqvist, C., Mazzanti, A., Blom, N., Borggrefe, M., Camm, J., Elliott, P. M., Fitzsimons, D., Hatala, R., Hindricks, G., et al. (2015) · European Heart Journal · doi:10.1093/eurheartj/ehv316 · Cited by 3,893
Al-Khatib, S. M., Stevenson, W. G., Ackerman, M. J., Bryant, W. J., Callans, D. J., Curtis, A. B., Deal, B. J., Dickfeld, T., Field, M. E., Fonarow, G. C., et al. (2018) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2017.10.054 · Cited by 1,854
(2015) · Europace · doi:10.1093/europace/euv319 · Cited by 1,592
Al-Khatib, S. M., Stevenson, W. G., Ackerman, M. J., Bryant, W. J., Callans, D. J., Curtis, A. B., Deal, B. J., Dickfeld, T., Field, M. E., Fonarow, G. C., et al. (2018) · Circulation · doi:10.1161/cir.0000000000000549 · Cited by 724
Al-Khatib, S. M., Stevenson, W. G., Ackerman, M. J., Bryant, W. J., Callans, D. J., Curtis, A. B., Deal, B. J., Dickfeld, T., Field, M. E., Fonarow, G. C., et al. (2018) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2017.10.053 · Cited by 678
Al-Khatib, S. M., Stevenson, W. G., Ackerman, M. J., Bryant, W. J., Callans, D. J., Curtis, A. B., Deal, B. J., Dickfeld, T., Field, M. E., Fonarow, G. C., et al. (2018) · Heart Rhythm · doi:10.1016/j.hrthm.2017.10.035 · Cited by 669
Al-Khatib, S. M., Stevenson, W. G., Ackerman, M. J., Bryant, W. J., Callans, D. J., Curtis, A. B., Deal, B. J., Dickfeld, T., Field, M. E., Fonarow, G. C., et al. (2018) · Heart Rhythm · doi:10.1016/j.hrthm.2017.10.036 · Cited by 629
Safety and Efficacy of the Totally Subcutaneous Implantable Defibrillator
Burke, M. C., Gold, M. R., Knight, B. P., Barr, C. S., Theuns, D. A. M. J., Boersma, L. V. A., Knops, R. E., Weiss, R., Leon, A. R., Herre, J. M., et al. (2015) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2015.02.047 · Cited by 505
Self-citationSubcutaneous or Transvenous Defibrillator Therapy
Knops, R. E., Olde Nordkamp, L. R. A., Delnoy, P.-P. H. M., Boersma, L. V. A., Kuschyk, J., El-Chami, M. F., Bonnemeier, H., Behr, E. R., Brouwer, T. F., Kääb, S., et al. (2020) · New England Journal of Medicine · doi:10.1056/nejmoa1915932 · Cited by 483
Self-citationLambiase, P. D., Barr, C., Theuns, D. A. M. J., Knops, R., Neuzil, P., Johansen, J. B., Hood, M., Pedersen, S., Kääb, S., Murgatroyd, F., et al. (2014) · European Heart Journal · doi:10.1093/eurheartj/ehu112 · Cited by 462
Self-citationAl-Khatib, S. M., Stevenson, W. G., Ackerman, M. J., Bryant, W. J., Callans, D. J., Curtis, A. B., Deal, B. J., Dickfeld, T., Field, M. E., Fonarow, G. C., et al. (2018) · Circulation · doi:10.1161/cir.0000000000000548 · Cited by 412
Implant and Midterm Outcomes of the Subcutaneous Implantable Cardioverter-Defibrillator Registry
Boersma, L., Barr, C., Knops, R., Theuns, D., Eckardt, L., Neuzil, P., Scholten, M., Hood, M., Kuschyk, J., Jones, P., et al. (2017) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2017.06.040 · Cited by 331
Self-citationWilkoff, B. L., Fauchier, L., Stiles, M. K., Morillo, C. A., Al-Khatib, S. M., Almendral, J., Aguinaga, L., Berger, R. D., Cuesta, A., Daubert, J. P., et al. (2016) · Heart Rhythm · doi:10.1016/j.hrthm.2015.11.018 · Cited by 301
Efficacy and Safety of an Extravascular Implantable Cardioverter–Defibrillator
Friedman, P., Murgatroyd, F., Boersma, L. V. A., Manlucu, J., O’Donnell, D., Knight, B. P., Clémenty, N., Leclercq, C., Amin, A., Merkely, B. P., et al. (2022) · New England Journal of Medicine · doi:10.1056/nejmoa2206485 · Cited by 255
Self-citation
Metadata
- Authors
- Weiss, R., Knight, B. P., Gold, M. R., Leon, A. R., Herre, J. M., Hood, M., Rashtian, M., Kremers, M., Crozier, I., Lee, K. L., Smith, W., & Burke, M. C.
- Venue
- Circulation
- Published
- 2013-08-27
- Volume
- 128
- Issue
- 9
- Pages
- 944-953
- ISSN
- 0009-7322 (ISSN-L)
- 1524-4539
- OpenAlex
- W2116287860
- Cited by
- 557
- References
- 29
- FWCI
- 33.68
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.